Makale
Tam Makale
Uluslararası
2021
Açık erişimli
Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
JOURNAL OF MEDICAL VIROLOGY
Cilt 93 · Sayı 4 · ss. 2090–2098 · 01.04.2021
Özet
Background Many laboratory parameters have been associated with morbidity and mortality in SARS-CoV-2 (COVID-19), which emerged in an animal market in Wuhan, China in December 2019 and has infected over 20 million people. This study investigated the relationship between serum interleukin (IL)-18, IL-1 receptor antagonist (IL-1Ra), and alpha defensin levels and the clinical course and prognosis of COVID-19.
Anahtar kelimeler
COVID-19
alpha defensin
IL-18
IL-1Ra
Sürdürülebilir Kalkınma Amaçları
-
SKA 3: Sağlıklı Bireyler
-
SKA 16: Barış, Adalet ve Güçlü Kurumlar
Atıf için künye
Kerget, B., Kerget, F., Aksakal, A., Aşkın, S., Sağlam, L., & Akgün, M. (2021). Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome. JOURNAL OF MEDICAL VIROLOGY, 93(4), 2090–2098. https://doi.org/10.1002/jmv.26589
BibTeX
@article{kerget2021-226905,
author = {Kerget, Buğra and Kerget, F and Aksakal, Alperen and Aşkın, Seda and Sağlam, Leyla and Akgün, Metin},
title = {Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.},
journal = {JOURNAL OF MEDICAL VIROLOGY},
year = {2021},
volume = {93},
number = {4},
pages = {2090--2098},
issn = {0146-6615},
doi = {10.1002/jmv.26589},
url = {https://akademik.atauni.edu.tr/yayinlar/226905-evaluation-of-alpha-defensin-il-1-receptor-antagonist-and-il-18-levels-in-covid}
}